Tandem and Eli Lilly carried out trials to demonstrate the advantages of using Lyumjev in combination with Control-IQ ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...

The global rapid-acting insulin market is expected to grow at a CAGR of 4.75% and reach US$ 11.17 billion by 2032, from US$ 7.36 billion in 2023. The market is mainly driven by growth rate of diabetes ...

Type 2 diabetes is characterized by the body's inability to use insulin effectively. Insulin is a hormone that helps regulate metabolism properly. The condition is the most common type of ...

A series of case reports to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept), describe how a technology giving insulin doses ...

Medicare Part B covers diabetes test strips as a type of durable medical equipment. Learn how to qualify for coverage and ...

Diabetes is a global health problem. Those who suffer from this disease produce little or no insulin, or have an ineffective ...

Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetesWith a single sensor, the ...

Despite high use of continuous glucose monitoring and insulin pump therapy, fear of hypoglycaemia (low blood ... by contributing institutions or for the use of any information through the EurekAlert ...

Automated insulin delivery systems have, for the first time, been tested for people with type-one diabetes and end-stage ...

"It is important to find out which factors in these foods are responsible for these associations," researcher Suvi Virtanen said.